Is It Safe to Take Semaglutide While Pregnant? Navigating Weight Management and Family Planning

The journey to a healthier life often involves navigating complex decisions, especially when it intersects with major life events like planning a family. For many individuals managing their weight with medications like semaglutide, questions naturally arise about how these treatments interact with pregnancy. This is not just a medical question; it’s a deeply personal one, touching on hopes for the future and the well-being of both parent and child. Understanding the current medical recommendations and the nuances behind them is crucial for anyone considering pregnancy while on weight loss medication.

At TrimRx, our journey began with a shared vision to help individuals embrace healthier lifestyles by merging cutting-edge telehealth innovations with effective weight loss solutions. We understand that achieving sustainable weight loss is a personal and often challenging endeavor, which is why our platform is designed to be a user-friendly and supportive space where individuals receive personalized, medically supervised care. Our approach is built on the belief that sustainable weight loss should be achieved through science, empathy, and a transparent approach, ensuring that every step of your health journey is guided by expert care and clear information.

This comprehensive guide will delve into the current understanding of semaglutide use during pregnancy and breastfeeding, drawing upon the latest research and expert recommendations. We will explore what semaglutide is, the potential implications for fertility, and the critical considerations for discontinuing medication when planning a pregnancy. Furthermore, we will examine the limited human and extensive animal study data regarding potential risks, alongside the broader implications of weight management during this delicate period. Our aim is to empower you with the knowledge to have informed discussions with your healthcare provider, ensuring decisions are made with your long-term health and family goals in mind. We will also highlight how TrimRx supports individuals in achieving their health goals responsibly, whether they are preparing for pregnancy or maintaining a healthy lifestyle.

Understanding Semaglutide: A GLP-1 Receptor Agonist

Semaglutide belongs to a class of medications known as glucagon-like peptide-1 (GLP-1) receptor agonists. These medications mimic the action of a natural hormone in your body called GLP-1, which plays a vital role in regulating blood sugar and appetite.

How Semaglutide Works

When you eat, GLP-1 is released from your gut, signaling to your brain that you are full, slowing down gastric emptying, and stimulating insulin release in response to high blood sugar. Semaglutide enhances these natural processes, leading to several key benefits:

• Improved Blood Sugar Control: For individuals with type 2 diabetes, semaglutide helps lower blood glucose levels by increasing insulin secretion when blood sugar is high and reducing glucose production by the liver.
• Reduced Appetite and Increased Satiety: By acting on receptors in the brain, semaglutide helps reduce hunger signals and promotes a feeling of fullness, which can lead to decreased food intake.
• Delayed Gastric Emptying: This slows down the rate at which food leaves the stomach, contributing to prolonged satiety and helping to stabilize blood sugar levels.

These combined effects make semaglutide a powerful tool for managing type 2 diabetes and, crucially, for facilitating weight loss.

Forms and Uses of Semaglutide

Semaglutide is available in various forms, primarily as an injectable medication and an oral tablet:

• Injectable Forms:
  • Ozempic®: Primarily prescribed to improve blood sugar control in adults with type 2 diabetes, often leading to significant weight loss as a secondary benefit.
  • Wegovy®: Specifically approved for chronic weight management in adults and adolescents over 12 years old who have obesity or are overweight with at least one weight-related comorbidity.
• Oral Form:
  • Rybelsus®: An oral tablet formulation approved for adults with type 2 diabetes to improve blood sugar control.

At TrimRx, we recognize that each individual’s needs are unique. That’s why we offer a range of personalized solutions, including various forms of semaglutide, such as Compounded Semaglutide and Oral Semaglutide, alongside the branded medications like Ozempic® and Wegovy®. Our medications are provided through FDA-registered, inspected, and approved pharmacies, ensuring the highest standards of safety and quality. To discover if one of these personalized options is right for you, we encourage you to take our free assessment quiz.

The Interplay of Weight Management and Pregnancy

Pregnancy is a period of profound physiological changes, and optimal maternal health is paramount for the well-being of both the expectant parent and the developing fetus. For individuals who are pregnant or planning to become pregnant, weight management takes on a unique and delicate dimension.

Why Intentional Weight Loss is Not Recommended During Pregnancy

A common and critical piece of medical advice is that intentional weight loss is generally not recommended during pregnancy. While maintaining a healthy weight is important before conception, the focus shifts during pregnancy to appropriate weight gain to support fetal growth and development. Losing significant weight during pregnancy, whether through dietary restriction, intense exercise, or medication, has been associated with adverse outcomes for the baby, including being born smaller than average (small for gestational age).

Healthcare providers instead focus on managing weight gain within healthy ranges, addressing nutritional needs, and ensuring overall maternal and fetal health through diet and exercise.

The Risks of Untreated Obesity and Type 2 Diabetes During Pregnancy

It’s important to acknowledge that while intentional weight loss during pregnancy is discouraged, untreated conditions like obesity and type 2 diabetes also pose significant risks to both parent and child. These risks can be substantial:

• For the Mother: Increased risk of gestational diabetes, preeclampsia (high blood pressure during pregnancy), sleep apnea, induction of labor, cesarean delivery, anesthesia complications, postpartum hemorrhage, wound complications, deep vein thrombosis/pulmonary embolism, and postpartum depression.
• For the Fetus/Child: Higher chances of birth defects, macrosomia (large for gestational age), preterm birth, stillbirth, and potential long-term health issues for the child, including a predisposition to obesity and diabetes later in life.

This complex interplay underscores the importance of pre-conception planning and careful medical management of underlying conditions. Our compassionate care respects every individual’s unique journey, combining advanced medical science with modern technology to support you in every stage of your health goals, including preparing for pregnancy.

Semaglutide and Pregnancy: Current Recommendations and Research

When considering the use of semaglutide during pregnancy, the prevailing medical advice is one of caution and prudence, largely due to the limited human data and the findings from animal studies.

Manufacturer Recommendations and Drug Clearance

The product labels for branded semaglutide medications like Ozempic®, Wegovy®, and Rybelsus® uniformly recommend that women who are planning a pregnancy should discontinue the medication at least two months before conception. This recommendation is based on the time it takes for semaglutide to clear from the body. On average, in healthy non-pregnant adults, it can take up to six weeks for most of the medication to be gone from the system. The two-month buffer provides an additional safety margin, ensuring minimal drug presence at the time of conception and during early embryonic development.

For those actively trying to conceive or for whom pregnancy is a possibility, discussions with a healthcare provider about stopping semaglutide or exploring alternative treatments are essential. Our comprehensive service includes doctor consultations, ensuring you receive personalized medical advice tailored to your specific circumstances and health goals.

The Role of Animal Studies

Due to ethical considerations, medications are not typically tested on pregnant humans. Therefore, much of our initial understanding of semaglutide’s potential effects during pregnancy comes from animal studies. These studies, conducted by manufacturers, have shown:

• Increased Chance of Birth Defects: In pregnant rats, exposure to semaglutide was associated with structural abnormalities and growth issues. Pregnant rabbits and cynomolgus monkeys also showed increased rates of structural abnormalities in their offspring. It is important to note that these effects often occurred at doses higher than those used in humans and were sometimes observed when the amount of semaglutide given was toxic to the mother animal.
• Fetal Death and Miscarriage: Animal studies also reported a higher chance for fetal death and miscarriage. However, it’s often unclear whether these findings were solely due to the medication itself or potentially confounded by significant maternal weight loss observed in the study animals.
• Growth Issues: Offspring exposed in animal studies were sometimes smaller than usual, with lower-than-average birth weights. Again, the role of maternal weight loss as a contributing factor is a consideration.

While animal studies provide valuable insights and form the basis for cautious recommendations, it’s crucial to remember that findings in animals do not always directly translate to humans.

Limited Human Data: Emerging Insights

Research on semaglutide use in human pregnancies is, by nature, limited, but new data is gradually emerging.

• Early Case Reports and Cohort Studies: A few isolated case reports describe women who inadvertently continued semaglutide for the first 3-4 weeks of pregnancy and subsequently gave birth to children without reported birth defects. More recently, a study analyzing outcomes for 168 pregnant women using GLP-1s, including 51 who took semaglutide, did not report an increased chance of birth defects.
• Recent Danish Cohort Study: A significant cohort study in Denmark, involving over 100,000 pregnancies, specifically examined 32 pregnancies exposed to semaglutide (27 with Ozempic, 5 with Wegovy) during the first trimester. This study reported no increased risk of major malformations among semaglutide-exposed pregnancies when compared to pregnancies exposed to insulin or unexposed pregnancies.
  • However, compared to unexposed pregnancies, semaglutide exposure was associated with increased risks of preterm birth, large for gestational age (LGA), neonatal hypoglycemia, and jaundice.
  • Crucially, these risks were found to be similar to those observed in insulin-exposed pregnancies, suggesting that the underlying maternal conditions (such as diabetes, higher BMI, and older maternal age, which were prevalent in the semaglutide group) might be significant contributing factors, rather than the semaglutide itself.
  • The authors of this study emphasized that despite these findings, the power of the study was limited due to the small number of semaglutide-exposed pregnancies, and it remains unsafe to revise the recommendation against its use during pregnancy. They highlight the need for larger studies.

These emerging human studies, while promising regarding major malformations, still underscore the need for caution. The overall picture, supported by current product labels and medical organizations, is that semaglutide is generally not recommended during pregnancy due to the limited human data and potential risks highlighted by animal studies, and the overarching guidance against intentional weight loss during pregnancy.

Unplanned Pregnancies and Semaglutide

Life, as we know, is full of surprises. Despite careful planning, unintended pregnancies can occur, sometimes when an individual is actively taking semaglutide or other weight loss medications. This scenario presents a unique set of challenges and demands immediate, informed action.

Immediate Discontinuation and Medical Consultation

If you discover you are pregnant while taking semaglutide, the most important first step is to immediately discontinue the medication and contact your healthcare provider. This cannot be stressed enough. Your doctor will provide guidance on monitoring your health and the pregnancy. At TrimRx, we prioritize your safety and well-being. Our approach includes unlimited support, ensuring you have access to expert guidance throughout your weight loss journey, including critical moments like an unexpected pregnancy.

Navigating the Transition Off Medication

Suddenly stopping semaglutide can lead to a phenomenon often described as “withdrawal symptoms,” though it’s more accurately characterized as the return of previous physiological states. Individuals may experience:

• Rapid Weight Regain: Without the appetite-suppressing and metabolic effects of semaglutide, hunger can return intensely, potentially leading to rapid regain of weight previously lost. This can be emotionally challenging and physically impactful.
• Return of Underlying Conditions: For individuals who were taking semaglutide for type 2 diabetes, blood sugar control may become more challenging, necessitating adjustments to other diabetes management strategies.

During this transition, comprehensive support focusing on lifestyle interventions becomes even more critical. Your healthcare provider, often in collaboration with nutritionists or behavioral therapists, can help you develop a robust plan centered on diet, physical activity, and behavior modification. This patient-focused approach mirrors TrimRx’s commitment to supporting individuals through every phase of their health journey, even when medical interventions need to change. We believe in providing the tools and knowledge to make this transition as smooth and healthy as possible.

The “Ozempic Babies” Phenomenon and Fertility Implications

A growing discussion has emerged around “Ozempic babies,” referring to an apparent increase in unexpected pregnancies among individuals using GLP-1 medications. While not a medically recognized term, this phenomenon points to an interesting intersection of weight loss, metabolic health, and fertility.

• Obesity and Infertility: It is well-established that obesity can significantly impact fertility in women. Conditions like Polycystic Ovary Syndrome (PCOS), often linked to insulin resistance and obesity, can disrupt hormonal balance and ovulation, making conception more difficult.
• GLP-1s and Potential Fertility Improvement: By addressing underlying metabolic issues, improving insulin sensitivity, and promoting weight loss, GLP-1 medications may inadvertently improve fertility. Regularization of menstrual cycles and improved ovulatory function could occur as metabolic health improves, potentially increasing the chances of conception for individuals who previously struggled to get pregnant.
• Delayed Recognition of Pregnancy: For someone with a history of irregular menstrual cycles, a missed period might not immediately signal a pregnancy. This could lead to a longer period of unintentional semaglutide exposure during early pregnancy before the individual realizes they are pregnant and discontinues the medication.
• Interaction with Birth Control: It is also important to note that some GLP-1 medications, such as tirzepatide (Mounjaro® for diabetes, Zepbound® for weight loss), carry warnings about potentially rendering oral birth control pills less effective due to their effect on slowing gastric emptying. This can interfere with the absorption of oral contraceptives. For individuals using these medications, non-hormonal forms of birth control or alternative hormonal methods might be advised. Our commitment to transparent service highlights that our approach remains consistent regardless of dosage changes, emphasizing safe and effective solutions always.

These factors combine to create a scenario where improved fertility through weight loss, coupled with potential interactions with birth control or delayed pregnancy recognition, could lead to unexpected conceptions while on GLP-1 medications. This further underscores the vital importance of open communication with your healthcare provider about family planning goals before and during your weight management journey.

Semaglutide and Breastfeeding Considerations

Just as with pregnancy, the use of semaglutide while breastfeeding requires careful consideration due to limited research in human lactation.

Limited Data in Human Breast Milk

Currently, there is limited information available regarding the excretion of semaglutide into human breast milk and its potential effects on a breastfed infant. While some small studies have suggested that semaglutide may be present in breast milk in very small amounts or undetectable after certain injectable doses (e.g., up to 1.0 mg per week), comprehensive data is still lacking. Animal studies have indicated that semaglutide can get into breast milk, albeit at lower levels than in the parent’s plasma.

Manufacturer Recommendations for Oral Semaglutide (Rybelsus®)

Specifically for the oral form of semaglutide, Rybelsus®, the product label recommends against its use in women who are breastfeeding. This caution stems from a theoretical concern that the oral formulation could lead to higher levels of semaglutide in a nursing infant, though this has not been proven with published human data.

Importance of Medical Guidance

Given the unknowns, healthcare providers generally advise caution. If you are considering taking semaglutide while breastfeeding, it is crucial to consult with your healthcare provider and your baby’s pediatrician. They can discuss the potential benefits of continuing the medication for your health condition against the unknown risks to your infant, helping you make the most informed decision for your unique situation.

It’s also worth noting that rapid weight loss, regardless of the method, can sometimes impact milk production. Therefore, focusing on supportive lifestyle interventions during the postpartum period can be a beneficial approach for many new parents.

Paternal Exposure to Semaglutide

The question of whether a father’s use of semaglutide could affect fertility or increase the chance of birth defects in his offspring is also a relevant concern for family planning.

Current Research on Male Fertility

Studies specifically designed to assess the impact of semaglutide on male fertility (the ability to get a woman pregnant) or to determine if it increases the chance of birth defects above the background risk have not been conducted in humans.

However, one animal study reported no changes in male fertility when semaglutide was administered at doses comparable to those used in humans. Generally, exposures experienced by fathers or sperm donors are considered unlikely to significantly increase risks to a pregnancy.

As with all health decisions, men who are concerned about their medication use and family planning should discuss these matters with their healthcare provider.

TrimRx’s Approach to Personalized Weight Management and Family Planning

At TrimRx, we are dedicated to supporting your health journey with empathy, innovation, and trust. While the decision to use semaglutide during pregnancy is a clear medical contraindication, our commitment extends to helping you prepare for a healthier lifestyle, including family planning, with the utmost care and support. We believe in providing solutions that are not only effective but also safe and tailored to your individual needs at every stage of life.

Our Values in Action

Our platform embodies our values:

• Empathetic Care: We understand the profound desire to manage your weight and how this intertwines with your family goals. Our compassionate care respects every individual’s unique journey.
• Science-Backed Solutions: We merge advanced medical science with modern technology, offering clinically proven solutions for weight management. Our commitment to transparent service means our approach remains consistent, guided by the latest medical understanding and safety protocols.
• Safety First: We partner exclusively with FDA-registered and inspected pharmacies for the shipping of weight loss medications. This ensures that you receive high-quality medication, upholding our unwavering focus on safety. It’s important to clarify that while these pharmacies are FDA-registered and inspected, compounded medications are not FDA approved. Branded medications like Ozempic®, Zepbound®, Wegovy®, and Mounjaro® are FDA-approved.
• Personalized Support: We understand that preparing for pregnancy involves unique considerations. Our medically supervised programs are designed to be flexible and supportive, allowing for discussions about your health goals, including family planning, with qualified medical professionals.

Preparing for a Healthy Pregnancy with TrimRx

For individuals considering pregnancy, our primary goal is to help you achieve and maintain optimal health before conception. This proactive approach can significantly improve outcomes for both you and your future child.

• Personalized Treatment Plans: If you’re managing your weight with medications like Compounded Semaglutide, Oral Semaglutide, Ozempic®, Compounded Tirzepatide, Oral Tirzepatide, Mounjaro®, Zepbound®, or Wegovy®, our program emphasizes ongoing communication with your doctor. This ensures that any plans for pregnancy are thoroughly discussed, and medication discontinuation strategies are put in place well in advance, following medical recommendations. To explore our personalized options, we invite you to take our free assessment quiz. This comprehensive service includes doctor consultations, medication, lab work, unlimited support, and shipping, all with no hidden fees.
• Quick-Access Supplements for Holistic Wellness: Beyond prescription medications, we also offer quick-access supplements designed to support your overall wellness during your weight loss journey. Our GLP-1 Daily Support and Weight Loss Boost are available for immediate purchase to complement your healthy lifestyle. These can be valuable tools to support your body’s needs as you focus on nutrition, physical activity, and behavior modification.
• Emphasis on Lifestyle Interventions: For individuals transitioning off medication or focusing on pre-conception health, we strongly advocate for the foundational pillars of weight management: nutrition therapy, regular physical activity, and behavior modification. These strategies are safe and effective during pregnancy and breastfeeding, and our programs provide the resources and guidance to implement them successfully.

Our goal is to be your trusted partner, offering results-oriented care that is deeply personalized. We want to ensure that every decision about your health is made with confidence and clarity, supported by a team that understands and respects your individual circumstances.

Navigating Your Journey: Safe Weight Management Strategies When Planning Pregnancy

For individuals looking to start or expand their families, careful planning and collaboration with healthcare providers are key, especially when weight management is part of the picture. Focusing on healthy habits before conception can make a significant difference.

Pre-Conception Health Optimization

The period before pregnancy offers a unique opportunity to optimize your health. For those managing their weight, this means:

• Achieving a Healthy Weight Range: Working towards a healthy Body Mass Index (BMI) before conception can reduce many pregnancy-related risks associated with obesity and improve fertility.
• Managing Underlying Conditions: Ensuring conditions like type 2 diabetes or hypertension are well-controlled before pregnancy is paramount. Your healthcare provider can adjust medication regimens as needed to ensure safety during pregnancy.
• Nutritional Focus: Developing balanced eating habits that prioritize nutrient-dense foods is crucial for both your health and the early development of a fetus.

This proactive approach forms the cornerstone of a healthier pregnancy. At TrimRx, we are here to support you in achieving these pre-conception goals through our personalized programs and expert guidance.

Lifestyle Interventions During Pregnancy and Breastfeeding

Once pregnant or during breastfeeding, the emphasis shifts firmly to lifestyle-based interventions for weight management, as medical weight loss medications are generally contraindicated.

• Nutrition Therapy:
  • Balanced Diet: Focus on a nutrient-rich diet that provides adequate calories for both you and your growing baby. This includes plenty of fruits, vegetables, whole grains, lean proteins, and healthy fats.
  • Portion Control: While calorie restriction for weight loss is not recommended, mindful eating and appropriate portion sizes can help manage healthy weight gain.
  • Hydration: Staying well-hydrated is essential for overall health and supports lactation.
• Physical Activity:
  • Regular, Moderate Exercise: Most pregnant individuals can safely engage in at least 30 minutes of moderate-intensity exercise on most days of the week, with their doctor’s approval. This might include walking, swimming, prenatal yoga, or cycling on a stationary bike.
  • Benefits: Physical activity during pregnancy can improve mood, reduce the risk of gestational diabetes, alleviate back pain, and prepare your body for labor and delivery.
• Behavior Modification:
  • Stress Management: Pregnancy and new parenthood can be stressful. Practicing relaxation techniques, ensuring adequate sleep, and seeking support can be beneficial.
  • Mindful Eating: Paying attention to hunger and fullness cues, eating slowly, and avoiding emotional eating can contribute to healthy weight management.
  • Support Systems: Engaging with support groups, family, and friends can provide encouragement and accountability.

For ongoing wellness support, our GLP-1 Daily Support and Weight Loss Boost supplements are available to help maintain overall health as you focus on these fundamental lifestyle changes.

The Critical Role of Your Healthcare Team

Throughout your journey, your healthcare team – including your obstetrician, family doctor, and potentially an obesity medicine specialist – is your most valuable resource.

• Open Communication: Have frank and open discussions about your weight management history, any medications you are taking, and your family planning intentions.
• Personalized Guidance: Your team can provide tailored advice on safe weight gain ranges during pregnancy, appropriate exercise, and nutritional needs. They will also monitor for conditions like gestational diabetes and cardiovascular disease.
• Medication Management: For those on semaglutide or similar medications, your doctor will guide you through the process of safely discontinuing the medication before conception and managing your health through lifestyle changes during pregnancy and breastfeeding.

At TrimRx, we are committed to providing you with the comprehensive service that includes doctor consultations and unlimited support, ensuring you have the resources to make informed decisions and receive expert guidance every step of the way. We partner with you, empowering you to embrace healthier lifestyles through science, empathy, and a transparent approach. To start your personalized health journey and discuss your weight management goals in the context of family planning, we encourage you to take our free assessment quiz.

Conclusion

The question of whether it is safe to take semaglutide while pregnant elicits a clear, resounding message from the medical community: semaglutide is not recommended during pregnancy or while breastfeeding. This advice is rooted in the limited human data, the cautionary findings from animal studies that indicate potential risks, and the overarching principle that intentional weight loss during pregnancy is generally discouraged.

For those planning a family, the recommendation is to discontinue semaglutide at least two months before attempting conception, allowing ample time for the medication to clear the body. In cases of unplanned pregnancy while on semaglutide, immediate discontinuation and urgent consultation with a healthcare provider are paramount. While emerging human data offers some initial insights, the current consensus emphasizes caution, highlighting the need for extensive further research.

At TrimRx, our core mission is to empower individuals to achieve sustainable weight loss and embrace healthier lifestyles through personalized, medically supervised care. We believe in integrating cutting-edge telehealth innovations with empathy, transparency, and a steadfast commitment to safety. For individuals navigating the delicate balance of weight management and family planning, our approach focuses on supporting your pre-conception health and guiding you through effective, safe lifestyle strategies during pregnancy and breastfeeding. We offer comprehensive services, including doctor consultations, lab work, unlimited support, and access to medications provided through FDA-registered and inspected pharmacies (for both branded medications like Ozempic®, Wegovy®, Mounjaro®, and Zepbound® and compounded options like Compounded Semaglutide, Oral Semaglutide, Compounded Tirzepatide, and Oral Tirzepatide).

Your health journey is unique, and we are here to support every step of the way, helping you make informed decisions that honor your well-being and your family’s future. To explore our personalized programs and begin your path to sustainable health, we invite you to take our free assessment quiz. For immediate support for your overall wellness, consider our GLP-1 Daily Support or Weight Loss Boost supplements.

Frequently Asked Questions (FAQ)

Q1: Why is semaglutide generally not recommended during pregnancy?

Semaglutide is generally not recommended during pregnancy primarily due to limited human safety data and concerns raised by animal studies, which have shown potential risks such as birth defects, miscarriage, and growth issues in offspring. Additionally, medical professionals advise against intentional weight loss during pregnancy, as it can be detrimental to fetal development. Current guidelines suggest discontinuing semaglutide at least two months before conception to allow the medication to clear the body.

Q2: What should I do if I become pregnant while taking semaglutide?

If you discover you are pregnant while taking semaglutide, you should immediately stop the medication and contact your healthcare provider. Your doctor will provide personalized guidance on monitoring your health and the pregnancy. They can help you transition to safe lifestyle interventions for weight management and address any concerns regarding your underlying health conditions. TrimRx offers unlimited support to help guide you through such transitions.

Q3: Can semaglutide affect my fertility or my partner’s fertility?

While it is not definitively known if semaglutide directly makes it harder to get pregnant, improving metabolic health and achieving weight loss through medications like semaglutide can sometimes improve fertility, especially for individuals with obesity-related conditions like PCOS. For male partners, human studies on semaglutide’s effect on fertility are limited, but animal studies have not shown changes in male fertility at human-equivalent doses. Always discuss fertility concerns and family planning with your healthcare provider.

Q4: Is it safe to breastfeed while taking semaglutide?

There is limited information available on the safety of semaglutide during breastfeeding. While some studies suggest minimal transfer into breast milk after injectable forms, comprehensive human data is lacking. Manufacturers of oral semaglutide (Rybelsus®) specifically advise against its use while breastfeeding. Given these unknowns, it is crucial to consult your healthcare provider and your baby’s pediatrician to weigh the potential benefits of the medication against any unknown risks to your infant.